Attovia Therapeutics, Inc. (ATTO)

NASDAQ

$14.59

$+0.65

(+4.59%)

Regular Market

Attovia Therapeutics, Inc. (ATTO) Live Price Chart

Last updated: ⁦2026-10-21 19:43:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Attovia Therapeutics, Inc. (ATTO) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $14.59, with a market capitalization of $634.10M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $12.94 to $28.00. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$634.10M
Open	$14.02
Day's High	$73.60
Day's Low	$0.42
Previous Close	$14.04
Volume	90.78K
Average Volume	455.97K
P/E Ratio	--
52-Week High	$28.00
52-Week Low	$12.94
Dividend Yield	--
Earnings Date	--

Attovia Therapeutics, Inc. (ATTO) Stock Price Today

Attovia Therapeutics, Inc. (ATTO) is currently trading at $14.59 as of 2026-10-21 19:41:00, up 3.92% ($0.55) from the previous close of $14.04

During today's regular trading session, ATTO has traded between $0.42 and $73.60, with a trading volume of 90.78K shares. The current price is near the lower end of today's range.

Attovia Therapeutics, Inc. (ATTO) 7-Day Stock Price Change

Over the past seven days, Attovia Therapeutics, Inc. (ATTO) moved from $14.59 to $14.59, representing no net price change.

The stock traded between $12.94 and $16.30 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.

The average daily volume was 483.81 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

ATTO 52-Week Price Position

Position in Range: 11.0%

52W Low$12.94

52W High$28.00

ATTO is currently trading at $14.59, placing it 11.0% of the way from its 52-week low of $12.94 to its 52-week high of $28.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Attovia Therapeutics, Inc. (ATTO)?

Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.

Attovia Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange	NASDAQ
Company Website	https://www.attovia.com

How to Buy Attovia Therapeutics, Inc. (ATTO) Stock on MEXC

Eligible investors can buy real shares of Attovia Therapeutics, Inc. (ATTO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ATTO and Place Your Order

Open the RealStocks trading page and search for ATTO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Attovia Therapeutics, Inc. (ATTO) stock price today?

Attovia Therapeutics, Inc. (ATTO) is currently trading at $ 14.59, up 3.92% ($0.55) from the previous close of $ 14.04. Intraday prices update in real time during regular trading hours.

2.Is ATTO stock going up or down today?

As of 2026-10-21 19:41:00, ATTO is trading at $ 14.59, up 3.92% ($0.55) from its previous close of $ 14.04. The stock has traded between $ 0.42 and $ 73.60 during today’s regular session. Past price movements do not guarantee future results.

3.What is ATTO pre-market price?

As of 2026-10-21 19:41:00, ATTO is trading at $ 14.06 in pre-market trading, up 0.15% ($0.02) from the previous close of $ 14.04. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ATTO after-hours price?

As of 2026-10-21 19:41:00, ATTO is trading at $ 14.09 in after-hours trading, up 0.32% ($0.05) from the regular-session close of $ 14.04. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ATTO stock trading now?

ATTO trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ATTO sit relative to its 52-week high and low?

Over the past 52 weeks, ATTO has traded between a low of $ 12.94 and a high of $ 28.00. At $ 14.59, the stock is positioned 11.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Attovia Therapeutics, Inc. in?

Attovia Therapeutics, Inc. (ATTO) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Attovia Therapeutics, Inc.'s market capitalization and where is it listed?

Attovia Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 634.10M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ATTO valued in terms of P/E ratio and EPS?

ATTO trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Attovia Therapeutics, Inc. pay a dividend?

Attovia Therapeutics, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.